{
    "2018-10-24": [
        [
            {
                "time": "2018-10-24",
                "original_text": "Incyte (INCY) to Report Q3 Earnings: What's in the Cards?",
                "features": {
                    "keywords": [
                        "Q3 Earnings",
                        "Incyte"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-10-25",
                "original_text": "Pfizer Succeeds in Pain Study, Forms JV to Make CNS Drugs",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Pain Study",
                        "JV",
                        "CNS Drugs"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-10-24",
                "original_text": "Recommendations for Allergan on October 24",
                "features": {
                    "keywords": [
                        "Allergan",
                        "Recommendations"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-10-26",
                "original_text": "New pain drug from Pfizer and Eli Lilly shows promise as opioid alternative",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "Eli Lilly",
                        "pain drug",
                        "opioid alternative"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-10-27",
                "original_text": "Pfizer-Lilly non-opioid drug helps reduce osteoarthritis pain",
                "features": {
                    "keywords": [
                        "Pfizer-Lilly",
                        "non-opioid",
                        "osteoarthritis pain"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-04-01",
                "original_text": "CMTA Fast Tracks NDA Filing, USNA In Good Health, DERM To Report Data In Apr.",
                "features": {
                    "keywords": [
                        "CMTA",
                        "NDA Filing",
                        "USNA",
                        "DERM",
                        "Data"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}